China Oncology ›› 2014, Vol. 24 ›› Issue (4): 310-315.doi: 10.3969/j.issn.1007-3969.2014.04.012

Previous Articles     Next Articles

Advance in current management of patients with anaplastic thyroid carcinoma

CHEN Jing, HE Xia-yun   

  1. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Online:2014-04-30 Published:2014-05-06
  • Contact: HE Xia-yun E-mail: donganlu270hao@gmail.com

Abstract:

Anaplastic thyroid cancer (ATC) is the most aggressive thyroid tumor, with lower morbidity and higher mortality rates. Radical surgery could improve local control and survival rates. Conformal radiotherapy is superior to conventional radiotherapy, which could improve the patients quality of life. There are a few chemotherapeutic drugs against ATC, and the outcome of chemotherapy alone is modest. Concurrent chemoradiotherapy can prolong the survival. Targeted therapy brings new hope for refractory patients. Many cancer centers are exploring surgery, radiotherapy, chemotherapy, targeted therapy and other biological treatment of comprehensive application, in order to enhance the curative effect. This article reviewed the foregoing treatments for ATC.

Key words: Anaplastic thyroid cancer, Surgery, Radiotherapy, Chemotherapy, Targeted therapy